The FDA rejected Lykos Therapeutics’ application for MDMA-assisted therapy for PTSD in August 2024, and as of mid-2026 that decision stands. MDMA remains a Schedule I substance in the United States, meaning the only legal access pathways are through active...
Last Updated: May 2026 Is psychedelic therapy legal in the USA? The honest answer is: it depends entirely on where you live and what substance you are asking about. Oregon, Colorado, and New Mexico have licensed psilocybin programs for supervised adult use. Everywhere...
Ketamine vs. esketamine (Spravato) is one of the most common points of confusion for people exploring treatment-resistant depression options. Both work through a similar mechanism in the brain, but they differ in molecular composition, route of administration, FDA...
Couples psychedelic therapy is an emerging clinical area with early but substantive evidence behind it. Professionally supported shared experiences using MDMA or psilocybin can reduce relational rigidity, improve communication, and address post-trauma dynamics. They...
Research into psilocybin aging effects is accelerating, with preclinical studies pointing to neuroplasticity promotion, reduced neuroinflammation, and improvements in longevity biomarkers. The findings are genuinely interesting, but human data remains limited, and...
Last Updated: May 2026 Psychedelic therapy Ohio residents can legally access today means ketamine. Psilocybin remains a Schedule I substance in Ohio, West Virginia, and under federal law. Vermont is further along than most states in its policy process, but no legal...
